Transcatheter edge-to-edge repair for severe tricuspid regurgitation was safe and improved quality of life while reducing regurgitation severity.
Does Tricuspid TEER reduce the severity of tricuspid regurgitation and improve quality of life in patients with severe tricuspid regurgitation?
Tricuspid TEER is a safe intervention that successfully reduces regurgitation severity and improves quality of life in patients with severe tricuspid regurgitation.
Tasa de eventos absoluta: 0% vs 0%
Tricuspid TEER was safe for patients with severe tricuspid regurgitation, reduced the severity of tricuspid regurgitation, and was associated with an improvement in quality of life. (Funded by Abbott; TRILUMINATE Pivotal ClinicalTrials.gov number, NCT03904147.).
“While neither trial demonstrated a mortality benefit, these two trials showed that both T-TEER and TTVR were associated with a reduction in TR, reduction of symptoms and improvement in quality of life compared to medical therapy alone.”
Sorajja et al. (Sat,) reported a other. Transcatheter edge-to-edge repair for severe tricuspid regurgitation was safe and improved quality of life while reducing regurgitation severity.